Encainide


Encainide is a class IA antiarrhythmic drug that is no longer clinically used due to concerns of proarrhythmia. The CAST trial demonstrated increased mortality using encainide, flecainide and moricizine to suppress premature ventricular contractions after an acute coronary syndrome.